Alarko Gayrimenkul Yatirim Ortakligi AS (ALGYO) Fair Value & Analysis
Real Estate · TR · Market cap 6.8B TRY
Fair value as of: Jul 31, 2026
From 6 valuation models · updated today
Share price −17.2% over the past month.
What matters now
- The large discount to fair value meets weak quality (35/100). That raises the risk this is a value trap rather than a bargain.
- The price is below even our cautious bear case (4.20 TRY). The market is more pessimistic than our downside scenario.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
- As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.
Price vs Fair Value (12 months)
12‑month range 2.84 TRY – 8.21 TRY · fair‑value band 4.20 TRY – 7.06 TRY · the 3.33 TRY price screens below the 7.06 TRY fair value. As of Jul 31, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Alarko Gayrimenkul Yatirim Ortakligi AS (ALGYO) currently trades at 3.33 TRY, while our model-based Fair Value estimate is 7.06 TRY, implying the stock looks roughly 112.0% undervalued today. We read business quality at 35/100 (below-average quality), in the Real Estate sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.
Trailing-twelve-month revenue stands at 571M TRY. Revenue grew 28.2% year over year. It earns a return on equity of -13.3%. Net debt stands at 4.1B TRY. Fundamentals as of Jul 31, 2026
Our scenario range runs from 4.20 TRY (bear case) to 7.06 TRY (bull case); at 3.33 TRY, the current price sits below that range. The share trades about 60% below its 52-week high and 19% above its 52-week low, currently below its 200-day average. For context, the median of 10 Real Estate peers we cover trades at 3% fair-value upside, at 112%, ALGYO screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 31, 2026. TTM = trailing twelve months.
Quality Score breakdown
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Alarko Gayrimenkul Yatirim Ortakligi AS is registered in Istanbul and as published in the Turkish Trade Registry Gazette dated August 6, 1996.
Full company description
Alarko Gayrimenkul Yatirim Ortakligi AS is registered in Istanbul and as published in the Turkish Trade Registry Gazette dated August 6, 1996. On October 31, 1996, the Company applied to the Capital Markets Board (CMB or the Board) for a document regarding the registration of shares to be issued by joint stock companies for capital increases and was registered with the Board in accordance with the provisions of the Capital Markets Law with document numbered 1/1552 dated December 13, 1996, and REIT. Its primary activity is to engage in the objectives and subjects outlined in the Capital Markets Board (CMB) regulations regarding real estate investment trusts. Within this scope, the Company engages in investments in real estate, real estate projects, and capital market instruments. Accordingly, the Company complies with CMB regulations and relevant legislation regarding its operating principles, portfolio investment policies, and management limitations. Alarko Gayrimenkul Yatirim Ortakligi A.S. was incorporated in June 6, 1978 in Turkey.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Alarko Gayrimenkul Yatirim Ortakligi AS reported revenue of 555M TRL in FY2025 versus 122M TRL in FY2021, a compound +46.0%/yr. Reported net income was −2.0B TRL in FY2025.
Is ALGYO fairly valued? → Check now
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more REIT - Diversified stocks, each showing price versus our Fair Value estimate (as of Jul 31, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Goodman Group GMGSF | $21.70 | $5.24 | -76% |
| VICI Properties Inc VICI | $26.72 | $41.74 | +56% |
| W. P. Carey Inc WPC | $76.71 | $50.40 | -34% |
| Stockland STKAF | $3.00 | $2.58 | -14% |
| Charter Hall Group CTOUF | $15.42 | $10.05 | -35% |
| FNCDY FNCDY | $17.03 | $23.08 | +36% |
| GSEFF GSEFF | $63.01 | $89.17 | +42% |
| The GPT Group GPTGF | $3.63 | $2.41 | -34% |
| COV COV | €53.95 | €55.42 | +3% |
| Fibra Uno FUNO11 | 28.61 MXN | 55.86 MXN | +95% |
Compare Alarko Gayrimenkul Yatirim Ortakligi AS with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Real Estate stocks →
Frequently asked questions
Is Alarko Gayrimenkul Yatirim Ortakligi AS (ALGYO) overvalued or undervalued?
What is the fair value of ALGYO?
What is the quality score of ALGYO?
What is the revenue of Alarko Gayrimenkul Yatirim Ortakligi AS (ALGYO)?
What is the net profit margin of ALGYO?
Does Alarko Gayrimenkul Yatirim Ortakligi AS pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Alarko Gayrimenkul Yatirim Ortakligi AS and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.